Neuro-degenerative-illnesses-would-be-cured-with-RNAi-technology
Neuro-degenerative illnesses would be cured with RNAi technology
A gene-silencing technology has given new hope for people who developed rare neuro-degenerative diseases. Researchers in Massachusetts have produced postivie results with liver-sick people....
Tags: Genetics, Medical research, Therapeutics, Business, liver sick, liver sickness, RNAi tevhnology, drug development, gene-silnecing technology...
May 1, 2014
Research-and-Markets-PharmaPoint-Crohns-Disease-Current-and-Future-Players
Research and Markets: PharmaPoint: Crohn's Disease - Current and Future Players
Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Crohn's Disease Market. The report identifies and analyses the key companies shaping and driving the global Crohn's Disease ...
Tags: chrone disease, pharmaceutical research...
April 26, 2014
Daiichi-Sankyo-and-Agendia-will-work-togetheron-oncology-research
Daiichi Sankyo and Agendia will work togetheron oncology research
Agendia and Daiichi Sankyo today announced that they signed an agreement on further oncology drug development researches. Agendia is going to share its biomarker research with Daiichi, which is going to give in its clinical trial results....
Tags: Daiichi Sankyo, Agendia, drug development, clinical trials, biomarker research, oncology...
April 24, 2014
Huge-ampunts-of-money-invested-to-Flu-drugs-uselessly
Huge ampunts of money invested to Flu-drugs uselessly
According to a study millions of money is invested into drugs which are not better than the existing technologies, such as paracetamol. Taiflu might be one of them....
Tags: Tamiflu, drugs, flu drugs, durg spending, price of drugs, money wasted on drugs....
April 19, 2014
In-vivo-imaging-without-the-use-of-external-light
In vivo imaging without the use of external light
A bright luminescent protein is going to provide a solution for in vivo imaging without the use of external light. This improvement can revolutionize all the existing technologies. ...
Tags: drug, drug development, in vivo imaging, luminescent protein, internal imaging ...
April 12, 2014
Scripps-Florida-Scientists-has-a-new-research-towards-a-better-diabetes-drug
Scripps Florida Scientists has a new research towards a better diabetes drug
The Scripps Research institute has a new foundings in the field of common diabetes drugs. Ths surprising research result are hoped to lead scientist towards a more effecite treatment for high blood sugar index. ...
Tags: diabetes, diabetes drug, the scripps research institute, scripps diabetes, drug development, diabetic...
April 9, 2014
Cytokinetics-failed-FDAs-approval
Cytokinetics failed FDA's approval
Cytokinetics' new ASÉ drug has failed clinical trials and was not approved by FDA. The drug has not reached the efficiency endpoint, therefore further research is going to be needed....
Tags: drug, drug discovery, ASL drug, Cytokinetics asl drug, FDA approval, FDA approval of asl drugs....
April 29, 2014
Lillys-drug-and-Kadcyla-were-both-turned-down
Lilly's drug and Kadcyla were both turned down
Kadcyla unaffordable for NHS, Lilly's Alimta also turned down in NSCLC maintenance setting, but BI's Giotrif is approved for NSCLC subset...
Tags: pharmatimes, pharma, news, pemetrexed, NICE, NHS, Giotrif, Roche , Kadcyla, Alimta, breast cancer, NSCLC, afatinib, EGFR-TK, trastuzumab emtansine, CDF, ...
April 24, 2014
Gilead-gains-profit-from-controversial-Hepatitis-C-drug
Gilead gains profit from controversial Hepatitis C drug
Gilead Sciences announced that its income almost tripled thanks to Sovaldi. The controverisal Hepatitis C drug produced over $2.27B income for the developers....
Tags: AIDS and Healthcare foundation, Hepatitis C, hepatitis C drug, gilead, gilead news, Sovaldi, gilead profit...
April 24, 2014
GSKs-diabetes-Drug-got-an-FDA-okay
GSK's diabetes Drug got an FDA 'okay'
Taneum, the diabetes drug of GSK has been given a green light by FDA. With this 'okay' sign the pharmaceutical company can enter new markets....
Tags: pharmatimes, pharma news, Eperzan, approved, albiglutide, Tanzeum, GSK, drug development, pain, diabetes, diabetes drug, new treatment for diabetes....
April 19, 2014
Lemtrada-is-going-to-be-resubmitted-to-FDA-review
Lemtrada is going to be resubmitted to FDA review
Lemtrada, ths multiple sclerosis drug of Genzyme, a Sanofi company was once rejected by Food and Drug Administration. The resubmission aims to solve problems which were pointed out by FDA previously. ...
Tags: FDA, Lemtrada, multiple sclerosis, sanpfi, Genzyme, resubmission, ...
April 9, 2014
Scientist-see-a-new-hope-in-breast-cancer-treatments
Scientist see a new hope in breast cancer treatments
According to scientists "personal drugs" can be a new way in breast-cancer treatment. they found that almost all of the aggressively growing cells are from the sam genetic type - and via this discovery they are going to be able to develop new treatment....
Tags: treatment, drug, drug discovery, breast cancer, breast cancer drug...
April 4, 2014
MOST VIEWED
«« Prev 1 2 3 4 5 Next »» Last

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013